Advertisement

Topics

PubMed Journals Articles About "IMRT Lung Cancer" RSS

04:43 EDT 16th August 2018 | BioPortfolio

IMRT Lung Cancer PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest IMRT Lung Cancer articles that have been published worldwide.

More Information about "IMRT Lung Cancer" on BioPortfolio

We have published hundreds of IMRT Lung Cancer news stories on BioPortfolio along with dozens of IMRT Lung Cancer Clinical Trials and PubMed Articles about IMRT Lung Cancer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IMRT Lung Cancer Companies in our database. You can also find out about relevant IMRT Lung Cancer Drugs and Medications on this site too.

Showing "IMRT Lung Cancer" PubMed Articles 1–25 of 18,000+

Differences in lung injury after IMRT or proton therapy assessed by 18FDG PET imaging.

To compare lung injury among non-small cell lung cancer (NSCLC) patients treated with IMRT or proton therapy as revealed by 18F-FDG post-treatment uptake and to determine factors predictive for clinically symptomatic radiation pneumonitis.


Cardiac Sparing Whole Lung Imrt In Children With Wilms Tumor: Final Report On Technique And Abdominal Field Matching To Maximize Normal Tissue Protection.

Cardiac sparing whole lung (WL IMRT) has been shown to improve cardiac protection and lung volume dose coverage compared to standard anteroposterior techniques. This dosimetry study had 2 aims: 1). To determine the dosimetric advantages of a modified WL IMRT (M-WL IMRT) technique designed to reduce radiation exposure to the thyroid gland and breast tissues compared to the standard WL IMRT (S-WL IMRT) and 2). To determine the dosimetric advantages of M-WL IMRT and dosimetrically matched abdomen/flank RT fiel...

Using gEUD based plan analysis method to evaluate proton vs. photon plans for lung cancer radiation therapy.

The goal of this study was to exam the efficacy of current DVH based clinical guidelines draw from photon experience for lung cancer radiation therapy on proton therapy. Comparison proton plans and IMRT plans were generated for 10 lung patients treated in our proton facility. A gEUD based plan evaluation method was developed for plan evaluation. This evaluation method used normal lung gEUD(a) curve in which the model parameter "a" was sampled from the literature reported value. For all patients, the proton ...


Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.

Lung cancer is one of the deadliest malignancies. The immune checkpoint-blockade (ICB) tumor therapy has led to striking improvement of long-term survival for some lung cancer patients. However, the response rate of immunotherapy is still low for lung cancer. Studying the tumor microenvironment (TME) should shed light on improvement of immunotherapy of lung cancer. Interleukin-33 (IL-33), an "alarmin" cytokine, has been implicated in tumor associated immune responses and inflammatory diseases of the lung. T...

Compared with intensity-modulated radiotherapy, image-guided radiotherapy reduces severity of acute radiation-induced skin toxicity during radiotherapy in patients with breast cancer.

Radiotherapy (RT) is an effective treatment for breast cancer. The side effects of breast irradiation, including skin toxicity in the irradiation field, cause considerable discomfort. This study compared the severity of skin toxicity caused by image-guided RT (IGRT) and intensity-modulated RT (IMRT) combined with an electronic portal imaging device (EPID) in breast cancer. This study retrospectively analyzed 458 patients with breast cancer who had received RT. The patients were divided into two groups: 302 ...

Utilization of Neoadjuvant Intensity-modulated Radiation Therapy for Rectal Cancer in the United States.

Advances in technology have expanded the use of intensity-modulated radiotherapy (IMRT). The goal of this study was to investigate trends in the utilization of IMRT for rectal cancer (RC) in USA.

RapidArc vs Conventional IMRT for Head and Neck Cancer Irradiation: Is Faster Necessary Better?

Purpose: The aim of this study was to dosimetrically evaluate and compare double arc RapidArc (RA) with conventional IMRT (7 fields) plans for irradiation of locally advanced head and neck cancers (LAHNC), focusing on target coverage and doses received by organs at risk (OAR). Methods: Computed tomography scans of 20 patients with LAHNC were obtained. Contouring of the target volumes and OAR was done. Two plans were made for each patient, one using IMRT and the other double arc RA, and calculated doses to p...

Lung Cancer: One Disease or Many.

Lung cancer is classified as a single entity comprised of multiple histological subtypes. But how similar are these subtypes on a genetic level? This paper aims to address this question through a concise overview of germline and somatic differences between small cell lung cancer, lung adenocarcinoma, and lung squamous cell carcinoma.

Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study.

The relative risk of lung cancer decreases with years since quitting (YSQ) smoking, but risk beyond 25 YSQ remains unclear. Current lung cancer screening guidelines, which exclude smokers with more than 15 YSQ, may not detect lung cancers in this population.

Lung Cancer Health Disparities.

Compared with all other racial and ethnic groups in the U.S., African Americans are disproportionally affected by lung cancer, both in terms of incidence and survival. It is likely that smoking, as the main etiological factor associated with lung cancer, contributes to these disparities, but the precise mechanism is still unclear. This paper seeks to explore the history of lung cancer disparities and review to the literature regarding the various factors that contribute to them.

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility.

Chronic inflammation has been implicated in carcinogenesis, with increasing evidence of its role in lung cancer. We aim to evaluate the role of genetic polymorphisms in inflammation-related genes in the risk for developing lung cancer.

Lung Cancer Screening in the Community Setting.

Lung cancer has high incidence and high mortality burden particularly since it is typically diagnosed in later stages. The National Lung Screening Trial demonstrated a lung cancer specific mortality benefit in high risk current and former smokers with yearly low dose chest CT. Lung cancer screening is thus recommended but it is unclear if the results of the National Lung Screening Trial can be replicated in community settings.

Next generation sequencing assisted in establishing the diagnosis and treatment for a Chinese patient with breast and lung multiple primary malignancies.

A case of primary lung cancer was reported, which was misdiagnosed as breast cancer metastasis to the lung based on pathology in combination with a history of breast cancer.

Lung Cancer Screening Uncertainty among Patients Undergoing LDCT.

Lung cancer is the leading cause of cancer death, yet lung screening remains underutilized. Lung cancer screening uncertainty (LCSU), including referral clarity and the perceived accuracy of screening, may hinder utilization and represent an unmet psychosocial need. This study sought to identify correlates of LCSU among lung screening patients.

Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).

Self-reported smoking is the principal measure used to assess lung cancer risk in epidemiological studies. We evaluated if circulating cotinine-a nicotine metabolite and biomarker of recent tobacco exposure-provides additional information on lung cancer risk.

Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer.

Purpose To compare the toxicities and cost of proton radiation and stereotactic body radiotherapy (SBRT) with intensity-modulated radiotherapy (IMRT) for prostate cancer among men younger than 65 years of age with private insurance. Methods Using the MarketScan Commercial Claims and Encounters database, we identified men who received radiation for prostate cancer between 2008 and 2015. Patients undergoing proton therapy and SBRT were propensity score-matched to IMRT patients on the basis of clinical and soc...

Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening Trial.

Corrigendum to "Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer" Lung Cancer 114, (December 2017) 44-49.

Bullous lung diseases as a risk factor for lung cancer: A case report.

A possible association between lung cancer and bullous lung disease has been suggested and recently supported by the results of genetic studies.

Evaluation of the clinical application of multiple tumor marker protein chip in the diagnostic of lung cancer.

The early diagnostic of lung cancer plays an important role in the prognosis of surgical treatment among lung cancer patients. To evaluate the clinical application of multi-tumor markers protein biochip in the diagnosis of lung cancer, 12 tumor markers were detected in patients with different stages of lung cancer.

Racial disparities in lung cancer survival: The contribution of stage, treatment, and ancestry.

Lung cancer is a leading cause of cancer-related death worldwide. Racial disparities in LC survival exist between blacks and whites, yet are limited by categorical definitions of race. We sought to examine the impact of African ancestry on overall survival among black and white non-small cell lung cancer (NSCLC) cases.

Genomic Features of Response to Combination Immunotherapy in Lung Cancer.

In this issue of Cancer Cell, Hellmann et al. describe in two clinical trials the importance of tumor mutational burden as an independent predictive marker for outcomes with combination nivolumab plus ipilimumab as first-line therapy in metastatic non-small-cell lung cancer and in relapsed small-cell lung cancer.

A Plasma Long Noncoding RNA Signature for Early Detection of Lung Cancer.

The early detection of lung cancer is a major clinical challenge. Long noncoding RNAs (lncRNAs) have important functions in tumorigenesis. Plasma lncRNAs directly released from primary tumors or the circulating cancer cells might provide cell-free cancer biomarkers. The objective of this study was to investigate whether the lncRNAs could be used as plasma biomarkers for early-stage lung cancer. By using droplet digital polymerase chain reaction, we determined the diagnostic performance of 26 lung cancer-ass...

Emerging landscape of circular RNAs in lung cancer.

Lung cancer, the leading cause of cancer deaths worldwide, is characterized with malignant cell growth. Advances in next-generation sequencing has helped us further understand RNA and identify novel circular RNAs (circRNAs) that may be useful in the early diagnosis and treatment of lung cancer. Similar to other noncoding RNAs, circRNAs present diverse biological functions in normal and disease states, including various types of cancers. This review focuses mainly on the poorly understood functions of circ...

Lung cancer and particulate pollution: A critical review of spatial and temporal analysis evidence.

Particulate matter (PM) has been recognized as one of the key risk factors of lung cancer. However, spatial and temporal patterns of this association remain unclear. Spatiotemporal analyses incorporate the spatial and temporal structure of the data within random effects models, generating more accurate evaluations of PM-lung cancer associations at a scale that can better inform lung cancer prevention programs.


Advertisement
Quick Search
Advertisement
Advertisement